Life sciences stories
Anthropic deepens Australian push with AI safety pact, AUD $3 million research credits and data-sharing on model risks, jobs and adoption.
OpenAI expands its enterprise AI push with a biology-focused model aimed at speeding target discovery, analysis and early drug development.
AWS launches Amazon Bio Discovery to help drug researchers design and test molecules in one AI-driven workflow with wet-lab partners.
Anthropic strengthens its board with Novartis Chief Executive Officer Vas Narasimhan, giving its trust-appointed directors a majority.
Kvantify names Dr David Siebert as global head of business development as it steps up commercial push for hybrid quantum-classical software.
ACTO rolls out role-based AI SuperAgents for life sciences field teams, aiming to speed compliant access to approved content across sales and medical work.
AlphaSense boosts international leadership as it expands multilingual AI market intelligence across Europe, Asia-Pacific and beyond.
Nasuni pivots from cloud file storage with Active Everywhere and AI Activate, aiming to give enterprises governed access to unstructured data for AI.
Private equity-backed firms use paid AI tools more than most peers, but many still struggle to turn sponsor pressure into practical finance gains.
Tech Mahindra and ParkourSC deepen AI supply chain tie-up to target pharma and cold chain customers across global markets.
London Tech Week to launch dedicated Deep Tech Stage in 2026, with AI, quantum, space and life sciences speakers.
Carbery CogniMed, Love Better and Target Alert Group have been honoured after pitching to investors and local firms at UCC's IGNITE Spring Awards 2026.
British Business Bank makes GBP £100 million first close commitment to Apposite Healthcare Growth I, aiming to fill the UK's life sciences scale-up gap.
Helical secures USD $10 million seed round to scale its AI-powered drug discovery platform across more pharma programmes.
Oxford Science Enterprises names Antonia Jenkinson as Chief Financial Officer as it prepares for more regular portfolio realisations after a run of exits.
VID FIREKILL fits low-pressure water mist protection across two more buildings at Digital Realty's Paris Digital Park as hyperscale demand grows.
Canada deepens life sciences push with CAD $127m for Vancouver projects as Aspect Biosystems and Providence Health Care expand biomanufacturing and trials.
EY names 31 entrepreneurs from 24 firms as finalists in Ireland's 2026 award programme, spanning technology, health, construction and consumer sectors.
Conscience backs Canadian AI drug discovery teams with up to CAD $1 million as Ottawa supports open-science push.
British Business Bank adds GBP £10 million to Empirical Ventures to back deeptech 'venture scientists' and widen early-stage funding beyond London.